Literature DB >> 26051304

Adolescents with gender dysphoria.

Peggy T Cohen-Kettenis1, Daniel Klink2.   

Abstract

Young people with gender dysphoria are increasingly seen by pediatric endocrinologists. Mental health child specialists assess the adolescent and give advice about psychological or medical treatment. Provided they fulfill eligibility and readiness criteria, adolescents may receive pubertal suspension, consisting of using gonadotrophin-releasing hormone analogs, later followed by cross-sex hormones (sex steroids of the experienced gender). If they fulfill additional criteria, they may have various types of gender affirming surgery. Current issues involve safety aspects. Although generally considered safe in the short-term, the long-term effects regarding bone health and cardiovascular risks are still unknown. Therefore, vigilance is warranted during and long after completion of the last gender affirming surgeries. The timing of the various treatment steps is also under debate: instead of fixed age limits, the cognitive and emotional maturation, along with the physical development, are now often considered as more relevant.
Copyright © 2015. Published by Elsevier Ltd.

Entities:  

Keywords:  GnRHa analogs; adolescents; cross-sex hormones; gender dysphoria; gender incongruence

Mesh:

Substances:

Year:  2015        PMID: 26051304     DOI: 10.1016/j.beem.2015.01.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  6 in total

Review 1.  To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.

Authors:  Rosalia Costa; Polly Carmichael; Marco Colizzi
Journal:  Nat Rev Urol       Date:  2016-07-19       Impact factor: 14.432

2.  Parent reports of adolescents and young adults perceived to show signs of a rapid onset of gender dysphoria

Authors:  Lisa Littman
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

3.  "I knew that I wasn't cis, I knew that, but I didn't know exactly": Gender identity development, expression and affirmation in youth who access gender affirming medical care.

Authors:  Annie Pullen Sansfaçon; Denise Medico; Frank Suerich-Gulick; Julia Temple Newhook
Journal:  Int J Transgend Health       Date:  2020-05-13

Review 4.  Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population.

Authors:  Gloria Aranda; Irene Halperin; Esther Gomez-Gil; Felicia A Hanzu; Núria Seguí; Antonio Guillamon; Mireia Mora
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

5.  Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis.

Authors:  Lloyd J W Tack; Margarita Craen; Karlien Dhondt; Heidi Vanden Bossche; Jolien Laridaen; Martine Cools
Journal:  Biol Sex Differ       Date:  2016-02-16       Impact factor: 5.027

6.  Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study.

Authors:  Malin Indremo; Richard White; Thomas Frisell; Sven Cnattingius; Alkistis Skalkidou; Johan Isaksson; Fotios C Papadopoulos
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.